Pulsed Magnetic Therapy Revolutionizes Sports and Rehabilitative Medicine.

Business Editors & Medical Writers

ATLANTA--(BW HealthWire)--March 9, 2000

Professionals in the fields of sports medicine, physical therapy and rehabilitation can now safely treat a number of conditions with pain-free, non-invasive pulsed magnetic therapy. The new therapy system, called NeoTone(TM), was developed by Neotonus Inc., the world leader in applying pulsed magnetic fields to medicine, and provides quick, convenient patient treatments, even through clothing, padding and casts.

The new treatment utilizes a technology called Extracorporeal Magnetic Innervation [ExMI(TM)] to stimulate nerve activity, improving blood flow and enhancing the body's own healing process. ExMI, developed by Neotonus in 1997 in collaboration with Emory University School of Medicine and the Georgia Institute of Technology, was cleared by the U.S. Food and Drug Administration in May 1998 for use as a complete physical medicine and rehabilitative therapy system. Approved applications for NeoTone include muscle re-education, increasing local blood circulation, bulk muscle excitation, relaxation of muscle spasms, increasing range of motion, and prevention or retardation of disuse atrophy.

"We are excited to introduce this breakthrough technology to the many professionals whose work each day involves healing people," said NeoTone General Manager Patrick Dunigan. "Athletic trainers, physical therapists and chiropractors can now easily administer treatments without the use of electrodes, probes, creams or gels. NeoTone provides a quick, deep penetrative treatment, allowing players to return to the field and patients to resume their everyday activities much sooner than if they had been treated with a more traditional form of therapy."

Professionals can now use one device to treat a number of ailments, and unlike drugs and other therapies, there are no side effects. The initial product line consists of NeoTone Pro and NeoTone Pro-Plus. NeoTone Pro is a hand-held portable unit that conveniently allows treatment to be administered onsite or on the sidelines. NeoTone Pro-Plus incorporates the therapy head on a sliding arm into a standard training table that allows the clinician to treat all areas of the body. Treatment duration varies, but sessions typically last about 15 to 20 minutes and are given on an "as needed" basis for muscle spasms.

The baseline technology for NeoTone is similar to that of another Neotonus product, the NeoControl(R) Pelvic Floor Therapy System, which utilizes ExMI technology and was approved by the FDA in June 1998. NeoControl was developed to treat the most common cause of urinary incontinence, loss of pelvic floor muscle strength, and has been used in more than 200 urology and obstetrics/gynecology practices throughout the United States and 12 other countries.

Based in Marietta, Ga., Neotonus Inc. provides cost-effective, non-invasive healthcare solutions utilizing advanced pulsed magnetic neuromodulation technologies. The company holds several patents for a broad range of medical applications of its ExMI technology. For more information, call 1/800-895-4298 or visit www.neotonus.com.